IFI6 and hepatocellular carcinoma: Macrophage-CD9/IL18 expanded from HBV infection to HBV cirrhosis (P<0.05) (Figure 2B), while Macrophage-CD9/IFI6 were increasingly recognized during HCC development (P<0.05) (Figure 2B).